!!
#Depression increases the risk of inflammatory #bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression
https://gut.bmj.com/content/early/2018/10/18/gutjnl-2018-317182
We identified 403 665 (7.05%) patients with incident depression. Individuals with depression had a significantly greater risk of developing CD (adjusted HR=2.11, 95% CI 1.65 to 2.70) and UC (adjusted HR=2.23, 95% CI 1.92 to 2.60) after controlling for demographic and clinical covariates. SSRI and TCA were protective against CD, whereas mirtazapine, SNRI, SSRI, serotonin modulators and TCA were protective for UC.
Conclusion Patients with a history of depression were more likely to be diagnosed with IBD. In contrast, antidepressant treatments were selectively protective for Crohn’s disease and UC. These results may impact counselling and management of depression and IBD
#Depression increases the risk of inflammatory #bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression
https://gut.bmj.com/content/early/2018/10/18/gutjnl-2018-317182
We identified 403 665 (7.05%) patients with incident depression. Individuals with depression had a significantly greater risk of developing CD (adjusted HR=2.11, 95% CI 1.65 to 2.70) and UC (adjusted HR=2.23, 95% CI 1.92 to 2.60) after controlling for demographic and clinical covariates. SSRI and TCA were protective against CD, whereas mirtazapine, SNRI, SSRI, serotonin modulators and TCA were protective for UC.
Conclusion Patients with a history of depression were more likely to be diagnosed with IBD. In contrast, antidepressant treatments were selectively protective for Crohn’s disease and UC. These results may impact counselling and management of depression and IBD
!!
High Patient #Activation Is Associated With Remission in Patients With Inflammatory #Bowel Disease
https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izy378/5257738?redirectedFrom=fulltext
High levels of patient activation (having the knowledge, skills, and confidence to effectively manage one’s care), have been associated with improved outcomes in many chronic conditions. There have been few studies of the effects of activation in patients with inflammatory bowel disease (IBD). We performed a large, prospective Internet-based study to assess the relationship between patient activation level and clinical remission in patients with Crohn’s disease or ulcerative colitis.
Higher anxiety (adjusted odds ratio aOR, 0.32; 95% confidence interval CI, 0.29–0.36) and depression scores were associated with a decreased odds of high patient activation. After we adjusted for education status, smoking, medication use, and other confounders, we found that patients with high activation at baseline were more likely to be in clinical remission during the follow-up period.
In a large, prospective Internet-based cohort of patients with IBD, we found a strong association between patient activation and clinical remission. These findings suggest that patient activation affects disease outcomes.
High Patient #Activation Is Associated With Remission in Patients With Inflammatory #Bowel Disease
https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izy378/5257738?redirectedFrom=fulltext
High levels of patient activation (having the knowledge, skills, and confidence to effectively manage one’s care), have been associated with improved outcomes in many chronic conditions. There have been few studies of the effects of activation in patients with inflammatory bowel disease (IBD). We performed a large, prospective Internet-based study to assess the relationship between patient activation level and clinical remission in patients with Crohn’s disease or ulcerative colitis.
Higher anxiety (adjusted odds ratio aOR, 0.32; 95% confidence interval CI, 0.29–0.36) and depression scores were associated with a decreased odds of high patient activation. After we adjusted for education status, smoking, medication use, and other confounders, we found that patients with high activation at baseline were more likely to be in clinical remission during the follow-up period.
In a large, prospective Internet-based cohort of patients with IBD, we found a strong association between patient activation and clinical remission. These findings suggest that patient activation affects disease outcomes.
!!
Hospitalization Outcomes for #Inflammatory #Bowel Disease in Teaching vs Nonteaching Hospitals
https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izz089/5482270?redirectedFrom=fulltext
Hospitalizations contribute significantly to the annual health care expenditure for inflammatory bowel disease (IBD), and reducing cost of care without compromising outcomes is a rising priority. Teaching hospitals (THs) have higher costs and utilize trainees in care to a greater extent than community hospitals, and it is unknown how hospital teaching status (HTS) affects outcomes. We therefore sought to investigate the impact of HTS on IBD hospitalization outcomes.
Unadjusted mean LOS, mean DC, and 30-day RR were greater among THs for both UC and CD. Unadjusted MR was greater among major THs for UC but not CD. After multivariable analysis, only 30-day RR for UC was increased in major THs relative to non-THs (1.98%; 95% confidence interval, 0.33%–3.61%).
Conclusions
Differences in metrics of cost-effective hospital care for patients with IBD appear to be driven by disease severity rather than HTS. Future research should attempt to better characterize factors driving resource utilization for IBD hospitalizations.
Hospitalization Outcomes for #Inflammatory #Bowel Disease in Teaching vs Nonteaching Hospitals
https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izz089/5482270?redirectedFrom=fulltext
Hospitalizations contribute significantly to the annual health care expenditure for inflammatory bowel disease (IBD), and reducing cost of care without compromising outcomes is a rising priority. Teaching hospitals (THs) have higher costs and utilize trainees in care to a greater extent than community hospitals, and it is unknown how hospital teaching status (HTS) affects outcomes. We therefore sought to investigate the impact of HTS on IBD hospitalization outcomes.
Unadjusted mean LOS, mean DC, and 30-day RR were greater among THs for both UC and CD. Unadjusted MR was greater among major THs for UC but not CD. After multivariable analysis, only 30-day RR for UC was increased in major THs relative to non-THs (1.98%; 95% confidence interval, 0.33%–3.61%).
Conclusions
Differences in metrics of cost-effective hospital care for patients with IBD appear to be driven by disease severity rather than HTS. Future research should attempt to better characterize factors driving resource utilization for IBD hospitalizations.
!!
#Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory #Bowel Disease: A Nationwide Cohort Analysis
https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izz093/5487145?redirectedFrom=fulltext
Inflammatory bowel disease (IBD) entails a higher risk of infections, including those that could be prevented with immunizations. Current Advisory Committee on Immunization Practices and American College of Gastroenterology vaccine recommendations for patients with IBD are based on low levels of evidence.
The most common VPDs among patients with IBD were herpes zoster virus (HZV) (34.9%) and hepatitis B virus (31.6%), followed by influenza (22.1%). Pneumococcal pneumonia (9.1%) and hepatitis A virus (2.4%) were less common. Inpatients with IBD were twice as likely to have HZV when compared to non-IBD inpatients (odds ratios OR = 2.30 95% CI, 2.06–2.58, P < 0.0001) This finding was consistent for every study year. Pneumococcal pneumonia OR = 0.62 (95% CI, 0.52–0.74), P < 0.0001 and influenza OR = 0.72 (95% CI, 0.63–0.81), P < 0.0001 were significantly lower in the IBD population. There was no difference for other VPDs.
Conclusions
HZV was the most frequent VPD in IBD inpatients. Patients with IBD have a higher rate of hospital admissions with HZV and a lower rate of pneumococcal pneumonia and influenza admissions when compared with non-IBD patients. For other VPDs, patients with IBD have the same rate of admission as the general population.
#Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory #Bowel Disease: A Nationwide Cohort Analysis
https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izz093/5487145?redirectedFrom=fulltext
Inflammatory bowel disease (IBD) entails a higher risk of infections, including those that could be prevented with immunizations. Current Advisory Committee on Immunization Practices and American College of Gastroenterology vaccine recommendations for patients with IBD are based on low levels of evidence.
The most common VPDs among patients with IBD were herpes zoster virus (HZV) (34.9%) and hepatitis B virus (31.6%), followed by influenza (22.1%). Pneumococcal pneumonia (9.1%) and hepatitis A virus (2.4%) were less common. Inpatients with IBD were twice as likely to have HZV when compared to non-IBD inpatients (odds ratios OR = 2.30 95% CI, 2.06–2.58, P < 0.0001) This finding was consistent for every study year. Pneumococcal pneumonia OR = 0.62 (95% CI, 0.52–0.74), P < 0.0001 and influenza OR = 0.72 (95% CI, 0.63–0.81), P < 0.0001 were significantly lower in the IBD population. There was no difference for other VPDs.
Conclusions
HZV was the most frequent VPD in IBD inpatients. Patients with IBD have a higher rate of hospital admissions with HZV and a lower rate of pneumococcal pneumonia and influenza admissions when compared with non-IBD patients. For other VPDs, patients with IBD have the same rate of admission as the general population.
Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing #SARS-CoV-2 than Patients Without Inflammatory #Bowel Disease? Results From a Nationwide Veterans’ Affairs Cohort Study
https://2medical.news/2021/01/30/are-patients-with-inflammatory-bowel-disease-at-an-increased-risk-of-developing-sars-cov-2-than-patients-without-inflammatory-bowel-disease-results-from-a-nationwide-veterans-affairs-cohort-study/
The clinic course of SARS-CoV-2 among patients with inflammatory bowel disease (IBD) has been extensively studied. However, there is a paucity of data on whether patients with IBD have an increased risk of developing SARS-CoV-2 with compared with patients without IBD. METHODS: We conducted a nationwide retrospective cohort study in the US Veterans’ Affairs healthcare system from January 1, 2020, to June 30, 2020. We …
https://2medical.news/2021/01/30/are-patients-with-inflammatory-bowel-disease-at-an-increased-risk-of-developing-sars-cov-2-than-patients-without-inflammatory-bowel-disease-results-from-a-nationwide-veterans-affairs-cohort-study/
The clinic course of SARS-CoV-2 among patients with inflammatory bowel disease (IBD) has been extensively studied. However, there is a paucity of data on whether patients with IBD have an increased risk of developing SARS-CoV-2 with compared with patients without IBD. METHODS: We conducted a nationwide retrospective cohort study in the US Veterans’ Affairs healthcare system from January 1, 2020, to June 30, 2020. We …
Risk of #Inflammatory #Bowel Disease in Patients With #Atopic Dermatitis
https://2medical.news/2023/09/16/risk-of-inflammatory-bowel-disease-in-patients-with-atopic-dermatitis/
https://2medical.news/2023/09/16/risk-of-inflammatory-bowel-disease-in-patients-with-atopic-dermatitis/
2Medical.News
Risk of #Inflammatory #Bowel Disease in Patients With #Atopic Dermatitis
Data on the association between atopic dermatitis (AD) and inflammatory bowel disease (IBD) are inconsistent. Few studies have examined the association of AD or AD severity with risk of ulcerative …
Examining the Association between #Coffee Intake and the Risk of Developing #Irritable #Bowel Syndrome: A Systematic Review and Meta-Analysis
https://2medical.news/2023/12/05/examining-the-association-between-coffee-intake-and-the-risk-of-developing-irritable-bowel-syndrome-a-systematic-review-and-meta-analysis/
https://2medical.news/2023/12/05/examining-the-association-between-coffee-intake-and-the-risk-of-developing-irritable-bowel-syndrome-a-systematic-review-and-meta-analysis/
2Medical.News
Examining the Association between #Coffee Intake and the Risk of Developing #Irritable #Bowel Syndrome: A Systematic Review and…
Abstract: Irritable bowel syndrome (IBS) is a highly prevalent disorder of braingut interaction with a significant impact on quality of life. Coffee is a widely consumed beverage with numerous bio…
#Migraine is associated with the development of adult patients with inflammatory #bowel disease: a nationwide, population-based study
https://2medical.news/2024/02/01/migraine-is-associated-with-the-development-of-adult-patients-with-inflammatory-bowel-disease-a-nationwide-population-based-study/
https://2medical.news/2024/02/01/migraine-is-associated-with-the-development-of-adult-patients-with-inflammatory-bowel-disease-a-nationwide-population-based-study/
2Medical.News
#Migraine is associated with the development of adult patients with inflammatory #bowel disease: a nationwide, population-based…
It has been reported that migraine is more common in patients with inflammatory bowel disease (IBD) than in general. However, the impact of migraine on the development of IBD has not yet been eluci…
Do interventions for mood improve #inflammatory biomarkers in inflammatory #bowel disease?: A systematic review and meta-analysis
https://2medical.news/2024/02/05/do-interventions-for-mood-improve-inflammatory-biomarkers-in-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis/
https://2medical.news/2024/02/05/do-interventions-for-mood-improve-inflammatory-biomarkers-in-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis/
2Medical.News
Do interventions for mood improve #inflammatory biomarkers in inflammatory #bowel disease?: A systematic review and meta-analysis
BackgroundPsychoneuroimmunological mechanisms and the gut-brain axis appear relevant to disease activity and progression in Inflammatory Bowel Disease (IBD). A recent review showed no effect of psy…
Opposing diet, #microbiome, and metabolite mechanisms regulate inflammatory #bowel disease in a genetically susceptible host
https://2medical.news/2024/03/29/opposing-diet-microbiome-and-metabolite-mechanisms-regulate-inflammatory-bowel-disease-in-a-genetically-susceptible-host/
https://2medical.news/2024/03/29/opposing-diet-microbiome-and-metabolite-mechanisms-regulate-inflammatory-bowel-disease-in-a-genetically-susceptible-host/
2Medical.News
Opposing diet, #microbiome, and metabolite mechanisms regulate inflammatory #bowel disease in a genetically susceptible host
Highlights•Dietary fiber-deprived gut microbiota elicits lethal colitis in Il10−/− mice•Mucolytic gut bacteria weaken mucus and drive inflammatory immune responses•Alterations in bacterial IgA coat…
The landscape of rare genetic variation associated with inflammatory #bowel disease and #Parkinson’s disease comorbidity
https://2medical.news/2024/05/20/the-landscape-of-rare-genetic-variation-associated-with-inflammatory-bowel-disease-and-parkinsons-disease-comorbidity/
https://2medical.news/2024/05/20/the-landscape-of-rare-genetic-variation-associated-with-inflammatory-bowel-disease-and-parkinsons-disease-comorbidity/
2Medical.News
The landscape of rare genetic variation associated with inflammatory #bowel disease and #Parkinson’s disease comorbidity
BackgroundInflammatory bowel disease (IBD) and Parkinson’s disease (PD) are chronic disorders that have been suggested to share common pathophysiological processes. LRRK2 has been implicated as pla…